Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
批准号:
10674749
负责人:
Karen R Jacobson
金额:
$92.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-07-31
关键词:
AccelerationAlcohol consumptionBostonCause of DeathCessation of lifeCharacteristicsClinicCluster AnalysisCocaineCommunicable DiseasesCommunitiesContact TracingCoughingDataDiagnosisDiseaseDisease OutbreaksDisease ProgressionDormutilDrug userExcretory functionFoundationsFrequenciesGene Expression ProfileGeneral PopulationHIVHIV InfectionsHIV/TBHouseholdIllicit DrugsIncidenceIndividualInfectionInterruptionInterventionInterviewInvestigationKnowledgeLiteratureMalnutritionMarijuanaMedical ResearchMedical centerMessenger RNAMethamphetamineMethaqualoneMolecular EpidemiologyNational Institute of Allergy and Infectious DiseaseOpioidParticipantPersonsPhysiologicalPopulationPrevalenceProspective StudiesProspective cohortPublic Health SchoolsReportingResearch PersonnelRespondentRiskSamplingSiteSmokeSmokingSocial NetworkSouth AfricaSouth AfricanStudy modelsSurveysTechniquesTimeTobaccoTreesTuberculosisUnited States National Institutes of HealthUniversitiesVulnerable PopulationsWhole Bloodarmburden of illnesscare seekingcase findingcohortcommunity transmissiondesigndisease transmissiondisorder riskepidemiological modelgenome sequencinghigh riskillicit drug useinsightmathematical modelmembermortalitynovelparticlerecruitsocial contacttranscriptomicstransmission processwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Tuberculosis (TB) is the leading infectious disease killer globally and leading cause of death in persons with
HIV. The most effective way to reduce TB incidence and mortality is to interrupt transmission. However, this
requires finding and treating individuals with TB disease early. The current primary approach to case finding—
household contact tracing—identifies <20% of transmissions in high burden settings, leaving a clear and
urgent need to identify new groups and settings where TB transmission occurs. Illicit drug use is associated
with higher TB infection prevalence and disease incidence, likely due to significant within-group transmission
and/or clustered vulnerability. Interrogation of illicit drug use networks for TB transmission, therefore, holds
great potential as a target for early case identification and linkage to treatment, with potential benefit for halting
transmission to the broader population. Investigators at Boston Medical Center, Stellenbosch University, the
South African Medical Research Council, Boston University School of Public Health and the Desmond Tutu
HIV Foundation propose to conduct the first study to assess TB risk and disease burden among illicit drug use
networks in a high TB/HIV setting and to identify mechanisms for accelerated transmission in this population.
We will use respondent driven sampling to recruit 750 individuals, with and without HIV disease, who smoke
illicit drugs (methamphetamine and methaqualone) and assess their TB exposure, risk of disease progression,
and TB disease burden. Among individuals found to have TB disease, we will leverage whole genome
sequencing and social contact interviews to estimate the proportion of cases in this network resultant from
recent transmission. We will capture cough frequency and use novel bioaerosol sampling techniques to
compare physiologic characteristics of infectiousness between persons who smoke illicit drugs compared to
those who do not. Knowledge from this study will provide the basis for a new, focused strategy to interrupt TB
transmission in persons who smoke illicit drugs and provide insight into the degree that such transmission fuels
overall community spread. These results have potential for generating interventions applicable to many
settings where illicit drug use intersects with TB and HIV.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41598-023-29804-5
发表时间:
2023-02-15
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Fofana, Abdou M., Moultrie, Harry, Scott, Lesley, Jacobson, Karen R., Shapiro, Anne N., Dor, Graeme, Crankshaw, Beth, Da Silva, Pedro, Jenkins, Helen E., Bor, Jacob, Stevens, Wendy S.]
通讯作者:
Stevens, Wendy S.
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.
非法药物使用联系之间结核病的传播(总计):使用受访者驱动的抽样的横断面观察研究方案。
DOI:
10.1371/journal.pone.0262440
发表时间:
2022
期刊:
PloS one
影响因子:
3.7
作者:
[Carney T, Rooney JA, Niemand N, Myers B, Theron D, Wood R, White LF, Meade CS, Chegou NN, Ragan E, Walzl G, Horsburgh R, Warren RM, Jacobson KR]
通讯作者:
Jacobson KR
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
-
批准号:10212938
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2019
-
负责人:Karen R Jacobson
-
依托单位:
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
-
批准号:10458601
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2019
-
负责人:Karen R Jacobson
-
依托单位:
The impact of alcohol consumption on TB treatment outcomes
-
批准号:9103779
-
项目类别:
-
资助金额:$69.84万
-
财政年份:2016
-
负责人:Karen R Jacobson
-
依托单位:
The impact of alcohol consumption on TB treatment outcomes
-
批准号:9901424
-
项目类别:
-
资助金额:$67.3万
-
财政年份:2016
-
负责人:Karen R Jacobson
-
依托单位:
Geospatial clustering and molecular and social epidemiology of drug resistant TB
-
批准号:8664054
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2013
-
负责人:Karen R Jacobson
-
依托单位:
Geospatial clustering and molecular and social epidemiology of drug resistant TB
-
批准号:8681578
-
项目类别:
-
资助金额:$14.34万
-
财政年份:2013
-
负责人:Karen R Jacobson
-
依托单位:
Geospatial clustering and molecular and social epidemiology of drug resistant TB
-
批准号:8334634
-
项目类别:
-
资助金额:$5.41万
-
财政年份:2011
-
负责人:Karen R Jacobson
-
依托单位:
Geospatial clustering and molecular and social epidemiology of drug resistant TB
-
批准号:8234217
-
项目类别:
-
资助金额:$14.26万
-
财政年份:2011
-
负责人:Karen R Jacobson
-
依托单位:
SWG1: HIV/TB Scientific Working Group
-
批准号:10454400
-
项目类别:
-
资助金额:$5.09万
-
财政年份:1998
-
负责人:Karen R Jacobson
-
依托单位:
SWG1: HIV/TB Scientific Working Group
-
批准号:10197768
-
项目类别:
-
资助金额:$3.71万
-
财政年份:1998
-
负责人:Karen R Jacobson
-
依托单位:
海外基金